308 related articles for article (PubMed ID: 28798259)
1. Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
Kato F; Sakao S; Takeuchi T; Suzuki T; Nishimura R; Yasuda T; Tanabe N; Tatsumi K
Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L899-L915. PubMed ID: 28798259
[TBL] [Abstract][Full Text] [Related]
2. Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.
Mizuno S; Farkas L; Al Husseini A; Farkas D; Gomez-Arroyo J; Kraskauskas D; Nicolls MR; Cool CD; Bogaard HJ; Voelkel NF
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):679-87. PubMed ID: 22842496
[TBL] [Abstract][Full Text] [Related]
3. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
[TBL] [Abstract][Full Text] [Related]
4. Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
Zungu-Edmondson M; Shults NV; Melnyk O; Suzuki YJ
PLoS One; 2017; 12(8):e0182551. PubMed ID: 28809956
[TBL] [Abstract][Full Text] [Related]
5. The selective PGI2 receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats.
Honda Y; Kosugi K; Fuchikami C; Kuramoto K; Numakura Y; Kuwano K
PLoS One; 2020; 15(10):e0240692. PubMed ID: 33057388
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin.
Van Hung T; Emoto N; Vignon-Zellweger N; Nakayama K; Yagi K; Suzuki Y; Hirata K
Life Sci; 2014 Nov; 118(2):313-28. PubMed ID: 24412382
[TBL] [Abstract][Full Text] [Related]
7. The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension.
Sakao S; Tatsumi K
Respiration; 2011; 81(3):253-61. PubMed ID: 21116108
[TBL] [Abstract][Full Text] [Related]
8. HIMF (Hypoxia-Induced Mitogenic Factor) Signaling Mediates the HMGB1 (High Mobility Group Box 1)-Dependent Endothelial and Smooth Muscle Cell Crosstalk in Pulmonary Hypertension.
Lin Q; Fan C; Gomez-Arroyo J; Van Raemdonck K; Meuchel LW; Skinner JT; Everett AD; Fang X; Macdonald AA; Yamaji-Kegan K; Johns RA
Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2505-2519. PubMed ID: 31597444
[TBL] [Abstract][Full Text] [Related]
9. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.
Oka M; Homma N; Taraseviciene-Stewart L; Morris KG; Kraskauskas D; Burns N; Voelkel NF; McMurtry IF
Circ Res; 2007 Mar; 100(6):923-9. PubMed ID: 17332430
[TBL] [Abstract][Full Text] [Related]
10. The Sugen 5416/Hypoxia Mouse Model of Pulmonary Arterial Hypertension.
Bueno-Beti C; Hadri L; Hajjar RJ; Sassi Y
Methods Mol Biol; 2018; 1816():243-252. PubMed ID: 29987825
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling.
Chaudhary KR; Deng Y; Suen CM; Taha M; Petersen TH; Mei SHJ; Stewart DJ
Br J Pharmacol; 2018 Oct; 175(20):3976-3989. PubMed ID: 30098019
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.
Taraseviciene-Stewart L; Kasahara Y; Alger L; Hirth P; Mc Mahon G; Waltenberger J; Voelkel NF; Tuder RM
FASEB J; 2001 Feb; 15(2):427-38. PubMed ID: 11156958
[TBL] [Abstract][Full Text] [Related]
13. Injury-Induced Shedding of Extracellular Vesicles Depletes Endothelial Cells of Cav-1 (Caveolin-1) and Enables TGF-β (Transforming Growth Factor-β)-Dependent Pulmonary Arterial Hypertension.
Oliveira SDS; Chen J; Castellon M; Mao M; Raj JU; Comhair S; Erzurum S; Silva CLM; Machado RF; Bonini MG; Minshall RD
Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1191-1202. PubMed ID: 30943774
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.
Grobs Y; Awada C; Lemay SE; Romanet C; Bourgeois A; Toro V; Nadeau V; Shimauchi K; Orcholski M; Breuils-Bonnet S; Tremblay E; Provencher S; Paulin R; Boucherat O; Bonnet S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805714
[TBL] [Abstract][Full Text] [Related]
15. Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416.
Woo E; Kato R; Imano H; Fujiwara Y; Ijiri Y; Okada Y; Yamaguchi T; Izumi Y; Yoshiyama M; Katsumata T; Hayashi T
Curr Vasc Pharmacol; 2017; 15(6):589-598. PubMed ID: 28460626
[TBL] [Abstract][Full Text] [Related]
16. Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.
Christou H; Hudalla H; Michael Z; Filatava EJ; Li J; Zhu M; Possomato-Vieira JS; Dias-Junior C; Kourembanas S; Khalil RA
J Pharmacol Exp Ther; 2018 Feb; 364(2):258-274. PubMed ID: 29212831
[TBL] [Abstract][Full Text] [Related]
17. A novel murine model of severe pulmonary arterial hypertension.
Ciuclan L; Bonneau O; Hussey M; Duggan N; Holmes AM; Good R; Stringer R; Jones P; Morrell NW; Jarai G; Walker C; Westwick J; Thomas M
Am J Respir Crit Care Med; 2011 Nov; 184(10):1171-82. PubMed ID: 21868504
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
[TBL] [Abstract][Full Text] [Related]
19. Clonally selected primitive endothelial cells promote occlusive pulmonary arteriopathy and severe pulmonary hypertension in rats exposed to chronic hypoxia.
Bhagwani AR; Farkas D; Harmon B; Authelet KJ; Cool CD; Kolb M; Goncharova E; Yoder MC; Clauss M; Freishtat R; Farkas L
Sci Rep; 2020 Jan; 10(1):1136. PubMed ID: 31980720
[TBL] [Abstract][Full Text] [Related]
20. Peptide-directed highly selective targeting of pulmonary arterial hypertension.
Urakami T; Järvinen TA; Toba M; Sawada J; Ambalavanan N; Mann D; McMurtry I; Oka M; Ruoslahti E; Komatsu M
Am J Pathol; 2011 Jun; 178(6):2489-95. PubMed ID: 21549345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
